Nutex Health Inc.
NUTX
$122.90
$4.443.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -76.28% | 802.02% | -2,314.37% | 0.00% | 98.85% |
| Total Depreciation and Amortization | -3.57% | 6.19% | 9.70% | 8.28% | -10.61% |
| Total Amortization of Deferred Charges | 6.35% | 5.45% | 5.42% | -41.37% | 971.12% |
| Total Other Non-Cash Items | 50.48% | 272.51% | 124.30% | 277.89% | -109.06% |
| Change in Net Operating Assets | 70.50% | -12,136.41% | -123.16% | 128.06% | 128.30% |
| Cash from Operations | 95,161.68% | -99.21% | -48.80% | 334.61% | 271.77% |
| Capital Expenditure | 83.81% | 35.97% | -10.57% | 23.85% | -188.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -100.00% | 149.21% | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 83.81% | -47.90% | 78.95% | -73.19% | -184.68% |
| Total Debt Issued | 255.97% | -63.56% | 45.39% | -26.85% | -27.47% |
| Total Debt Repaid | 34.56% | -66.48% | -42.05% | 62.33% | 11.21% |
| Issuance of Common Stock | -- | 171.33% | 385.58% | -96.73% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -54.57% | 3.43% | -- | -- |
| Cash from Financing | -128.12% | -609.29% | 64.59% | -120.91% | 245.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,424.83% | -154.54% | -43.51% | 34.95% | 265.90% |